Published in Proc Natl Acad Sci U S A on August 01, 1987
Neuronal NADPH diaphorase is a nitric oxide synthase. Proc Natl Acad Sci U S A (1991) 3.67
Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology (2010) 2.14
Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J Clin Invest (2010) 1.64
Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease. Exp Neurol (2008) 1.63
Turning heads: development of vertebrate branchiomotor neurons. Dev Dyn (2004) 1.46
The cholinergic system and Parkinson disease. Behav Brain Res (2010) 1.38
Functional circuitry involved in the regulation of whisker movements. J Comp Neurol (2002) 1.36
The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br J Pharmacol (2008) 1.29
Ageing and Parkinson's disease: why is advancing age the biggest risk factor? Ageing Res Rev (2014) 1.17
The transcription factor Pax6 regulates survival of dopaminergic olfactory bulb neurons via crystallin αA. Neuron (2010) 1.16
The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry (1988) 1.15
Parkinson's disease with camptocormia. J Neurol Neurosurg Psychiatry (2006) 1.14
Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain (2013) 1.12
Neuronal vulnerability, pathogenesis, and Parkinson's disease. Mov Disord (2012) 1.11
The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease. Front Comput Neurosci (2013) 1.06
Alpha oscillations in the pedunculopontine nucleus correlate with gait performance in parkinsonism. Brain (2012) 1.02
Sleep disturbances in Alzheimer's and Parkinson's diseases. Neuromolecular Med (2012) 1.00
Projections from the rat pedunculopontine and laterodorsal tegmental nuclei to the anterior thalamus and ventral tegmental area arise from largely separate populations of neurons. Brain Struct Funct (2011) 1.00
Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected. Pract Neurol (2014) 1.00
Pedunculopontine nucleus microelectrode recordings in movement disorder patients. Exp Brain Res (2008) 0.99
Role of nitric oxide on motor behavior. Cell Mol Neurobiol (2005) 0.97
Deep Brain Stimulation for Movement Disorders of Basal Ganglia Origin: Restoring Function or Functionality? Neurotherapeutics (2016) 0.96
Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep (2013) 0.95
Persons with Parkinson's disease exhibit decreased neuromuscular complexity during gait. Clin Neurophysiol (2013) 0.93
Parkinson's disease as a result of aging. Aging Cell (2015) 0.92
Cholinergic and non-cholinergic mesopontine tegmental neurons projecting to the subthalamic nucleus in the rat. Eur J Neurosci (2010) 0.91
Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function. Exp Neurol (2014) 0.91
The effects of deep brain stimulation on sleep in Parkinson's disease. Ther Adv Neurol Disord (2011) 0.91
Vestibular responses in the macaque pedunculopontine nucleus and central mesencephalic reticular formation. Neuroscience (2012) 0.89
Subthalamic nucleus versus pedunculopontine nucleus stimulation in Parkinson disease: synergy or antagonism? J Neural Transm (Vienna) (2011) 0.89
The pathology roadmap in Parkinson disease. Prion (2013) 0.88
Using motor imagery to study the neural substrates of dynamic balance. PLoS One (2014) 0.87
Our first decade of experience in deep brain stimulation of the brainstem: elucidating the mechanism of action of stimulation of the ventrolateral pontine tegmentum. J Neural Transm (Vienna) (2016) 0.86
The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement. Front Neurol (2013) 0.86
Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion. J Neurosci (2014) 0.86
Brain activity during complex imagined gait tasks in Parkinson disease. Clin Neurophysiol (2013) 0.84
Colocalization of nitric oxide synthase and somatostatin immunoreactivity in rat dentate hilar neurons. Proc Natl Acad Sci U S A (1994) 0.84
Extrinsic Sources of Cholinergic Innervation of the Striatal Complex: A Whole-Brain Mapping Analysis. Front Neuroanat (2016) 0.83
Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS One (2014) 0.83
Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion. J Neurophysiol (2013) 0.82
Neuronal loss in the caudal intralaminar thalamic nuclei in a primate model of Parkinson's disease. Brain Struct Funct (2013) 0.82
Physiological identification of the human pedunculopontine nucleus. J Neurol Neurosurg Psychiatry (2009) 0.82
Parkinson's disease. Subcell Biochem (2012) 0.82
Functional Neuroanatomy for Posture and Gait Control. J Mov Disord (2017) 0.82
Changes in the neuronal activity in the pedunculopontine nucleus in chronic MPTP-treated primates: an in situ hybridization study of cytochrome oxidase subunit I, choline acetyl transferase and substance P mRNA expression. J Neural Transm (Vienna) (2006) 0.81
Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systems. J Neural Transm (Vienna) (2015) 0.81
Deep brain stimulation of different pedunculopontine targets in a novel rodent model of parkinsonism. J Neurosci (2015) 0.81
Flow cytometry analysis of synaptosomes from post-mortem human brain reveals changes specific to Lewy body and Alzheimer's disease. Lab Invest (2014) 0.81
Pedunculopontine nucleus deep brain stimulation in Parkinson's disease. Arch Med Sci (2011) 0.80
The primate pedunculopontine nucleus region: towards a dual role in locomotion and waking state. J Neural Transm (Vienna) (2016) 0.78
PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. J Neurol (2015) 0.78
Advances in Therapeutic Options for Gait and Balance in Parkinson's Disease. US Neurol (2011) 0.78
The pedunculopontine tegmental nucleus: implications for a role in modulating spinal cord motoneuron excitability. J Neural Transm (Vienna) (2010) 0.78
The pedunculopontine tegmental nucleus and experimental parkinsonism. A review. J Neurol (2005) 0.78
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Mol Neurodegener (2015) 0.78
Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am J Pathol (2013) 0.77
Low frequency stimulation of the pedunculopontine nucleus modulates electrical activity of subthalamic neurons in the rat. J Neural Transm (Vienna) (2008) 0.77
Functional alpha7-containing nicotinic acetylcholine receptors localize to cell bodies and proximal dendrites in the rat substantia nigra pars reticulata. J Physiol (2008) 0.77
Pedunculopontine stimulation from primate to patient. J Neural Transm (Vienna) (2011) 0.77
Involvement of cholinergic system in hyperactivity in dopamine-deficient mice. Neuropsychopharmacology (2015) 0.77
Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Techniques, Side Effects, and Postoperative Imaging. Stereotact Funct Neurosurg (2016) 0.77
Parkinson's: a syndrome rather than a disease? J Neural Transm (Vienna) (2016) 0.76
The Proteasome Inhibition Model of Parkinson's disease. J Parkinsons Dis (2016) 0.76
Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline. Behav Neurosci (2015) 0.76
Pedunculopontine Nucleus Region Deep Brain Stimulation in Parkinson Disease: Surgical Anatomy and Terminology. Stereotact Funct Neurosurg (2016) 0.75
Maintaining balance against force perturbations: impaired mechanisms unresponsive to levodopa in Parkinson's disease. J Neurophysiol (2016) 0.75
Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson's Disease. J Alzheimers Dis Parkinsonism (2016) 0.75
Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine. J Neurol Neurosurg Psychiatry (1991) 0.75
New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease. Curr Pharmacol Rep (2016) 0.75
Cholinergic Oculomotor Nucleus Activity Is Induced by REM Sleep Deprivation Negatively Impacting on Cognition. Mol Neurobiol (2016) 0.75
Rapid Alleviation of Parkinson's Disease Symptoms via Electrostimulation of Intrinsic Auricular Muscle Zones. Front Hum Neurosci (2017) 0.75
Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias. Curr Neurol Neurosci Rep (2017) 0.75
Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human. Front Neurosci (2017) 0.75
Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci (1973) 7.85
Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience (1983) 3.26
The ascending cholinergic reticular system: neocortical, olfactory and subcortical projections. Brain (1967) 2.21
Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol (1983) 2.06
Projections of the lentiform nucleus in the monkey. Brain Res (1966) 1.79
The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol (1985) 1.60
Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res Bull (1986) 1.57
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci (1983) 1.51
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res (1982) 1.40
Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience (1984) 1.38
Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol (1985) 1.26
NADPH-diaphorase: a selective histochemical marker for the cholinergic neurons of the pontine reticular formation. Neurosci Lett (1983) 1.24
The afferent connections of the substantia innominata in the monkey, Macaca fascicularis. J Comp Neurol (1985) 1.18
On the descending control of the lumbosacral spinal cord from the "mesencephalic locomotor region". Acta Physiol Scand (1973) 1.08
Distribution of neuronal receptors for nerve growth factor in the rat. J Neurosci (1986) 1.08
Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc Natl Acad Sci U S A (1987) 1.06
Progressive supranuclear palsy: anatomoclinical and biochemical considerations. Adv Neurol (1987) 1.05
Projections of the pedunculopontine tegmental nucleus in the rat: evidence for additional extrapyramidal circuitry. Brain Res (1982) 1.04
Neurochemically specified subsystems in the basal ganglia. Ciba Found Symp (1984) 1.03
The afferent and efferent connections of the feline nucleus tegmenti pedunculopontinus, pars compacta. J Comp Neurol (1983) 1.01
Organization and efferent projections of nucleus tegmenti pedunculopontinus pars compacta with special reference to its cholinergic aspects. Neuroscience (1984) 0.99
A cholinergic projection to the rat superior colliculus demonstrated by retrograde transport of horseradish peroxidase and choline acetyltransferase immunohistochemistry. J Comp Neurol (1986) 0.98
Direct and indirect preoculomotor pathways of the brainstem: an autoradiographic study of the pontine reticular formation in the cat. J Comp Neurol (1977) 0.97
Neuropeptides and NADPH-diaphorase activity in the ascending cholinergic reticular system of the rat. Neuroscience (1986) 0.91
[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]. Rev Neurol (Paris) (1985) 0.90
Basal ganglia and other afferent projections to the peribrachial region in the rat: a study using retrograde and anterograde transport of horseradish peroxidase. Neuroscience (1981) 0.87
The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Brain Res (1986) 0.86
Distribution of central cholinergic neurons in the baboon (Papio papio). I. General morphology. J Comp Neurol (1985) 0.86
The basal ganglia-circa 1982. A review and commentary. Appl Neurophysiol (1981) 0.83
Cytochemical localization of brain nicotinamide adenine dinucleotide phosphate (oxidized)-dependent dehydrogenases. Qualitative and quantitative distributions. J Histochem Cytochem (1974) 0.81
A family of cAMP-binding proteins that directly activate Rap1. Science (1998) 6.12
The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain (1999) 4.25
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol Histopathol (1997) 3.80
Building neural representations of habits. Science (1999) 3.20
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (1988) 3.12
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol (2002) 3.02
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann Neurol (1994) 2.65
Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain (1991) 2.52
A Rap guanine nucleotide exchange factor enriched highly in the basal ganglia. Proc Natl Acad Sci U S A (1998) 2.47
Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell (1994) 2.46
Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease. Neurology (2009) 2.46
Large amounts of neocortical beta A4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person. Neurosci Lett (1990) 2.40
Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nat Genet (1995) 2.33
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem (1989) 2.26
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology (2004) 2.23
Responses of tonically active neurons in the primate's striatum undergo systematic changes during behavioral sensorimotor conditioning. J Neurosci (1994) 2.14
Neuroinflammatory processes in Parkinson's disease. Ann Neurol (2003) 2.10
Mitochondrial defect in Huntington's disease caudate nucleus. Ann Neurol (1996) 2.09
Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience (1996) 2.06
Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell (1994) 2.05
Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A (1978) 2.02
Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology (2006) 2.00
The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry. Brain (1999) 2.00
Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease. Proc Natl Acad Sci U S A (1997) 1.99
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc Natl Acad Sci U S A (2000) 1.97
Neurons in the thalamic CM-Pf complex supply striatal neurons with information about behaviorally significant sensory events. J Neurophysiol (2001) 1.94
Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content? J Neurochem (1992) 1.91
A single human gene encoding multiple tyrosine hydroxylases with different predicted functional characteristics. Nature (1987) 1.91
Mapping brain networks in awake mice using combined optical neural control and fMRI. J Neurophysiol (2010) 1.87
Interaction of beta-iodopenicillanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J (1982) 1.84
A measure of striatal function predicts motor stereotypy. Nat Neurosci (2000) 1.81
The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med (1992) 1.80
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Interaction of clavulanate with the beta-lactamases of Streptomyces albus G and Actinomadura R39. Biochem J (1982) 1.74
Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett (1994) 1.73
Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease. Brain Res (1983) 1.67
Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron (1996) 1.66
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet (1998) 1.64
Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's disease. J Neurochem (2002) 1.61
Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neuropathol (1998) 1.59
FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci (1999) 1.58
HIV-1-associated cognitive/motor complex: absence of neuronal loss in the cerebral neocortex. Neurology (1993) 1.56
Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J Neurosci (1995) 1.52
Temporal and spatial characteristics of tonically active neurons of the primate's striatum. J Neurophysiol (1995) 1.52
Effect of the nigrostriatal dopamine system on acquired neural responses in the striatum of behaving monkeys. Science (1994) 1.50
Oligodendroglial and neuronal inclusions in multiple system atrophy. Curr Opin Neurol (1993) 1.47
Impaired brain development and hydrocephalus in a line of transgenic mice with liver-specific expression of human insulin-like growth factor binding protein-1. Growth Horm IGF Res (2000) 1.47
Role of pontine nuclei damage in smooth pursuit impairment of progressive supranuclear palsy: a clinical-pathologic study. Neurology (1994) 1.46
Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron (1997) 1.44
Cortically driven immediate-early gene expression reflects modular influence of sensorimotor cortex on identified striatal neurons in the squirrel monkey. J Neurosci (1997) 1.42
Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease. Ann Neurol (1999) 1.40
Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia. Brain Res (1982) 1.40
Tetrode technology: advances in implantable hardware, neuroimaging, and data analysis techniques. J Neurosci Methods (2002) 1.37
The differential projection of two cytoarchitectonic subregions of the inferior parietal lobule of macaque upon the deep layers of the superior colliculus. J Comp Neurol (1985) 1.33
Is the mesocortical dopaminergic system involved in Parkinson disease? Neurology (1980) 1.32
Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron (1996) 1.31
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J Neurosci (2001) 1.31
Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder. Sleep Med (2013) 1.31
Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type. Acta Neuropathol (1986) 1.29
Abnormal Tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (1991) 1.28
Time-varying covariance of neural activities recorded in striatum and frontal cortex as monkeys perform sequential-saccade tasks. Proc Natl Acad Sci U S A (2005) 1.27
Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience (1993) 1.27
Subdivisions of the dopamine-containing A8-A9-A10 complex identified by their differential mesostriatal innervation of striosomes and extrastriosomal matrix. Neuroscience (1987) 1.27
Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol (1985) 1.26
Distributed but convergent ordering of corticostriatal projections: analysis of the frontal eye field and the supplementary eye field in the macaque monkey. J Neurosci (1992) 1.26
Somatostatin and dementia in Parkinson's disease. Brain Res (1983) 1.25
Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon: a role in nerve cell death? Neuroscience (1996) 1.24
[Cerebellar infarction in the area of the posterior cerebellar artery. Clinicopathology of 28 cases]. Rev Neurol (Paris) (1989) 1.24
Neurochemical architecture of the human striatum. J Comp Neurol (1997) 1.23
Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging. Neurosci Lett (1990) 1.20
Mutations in the SPG3A gene encoding the GTPase atlastin interfere with vesicle trafficking in the ER/Golgi interface and Golgi morphogenesis. Mol Cell Neurosci (2007) 1.19
Two input systems for body representations in the primate striatal matrix: experimental evidence in the squirrel monkey. J Neurosci (1993) 1.19
Corticostriatal transformations in the primate somatosensory system. Projections from physiologically mapped body-part representations. J Neurophysiol (1991) 1.18
Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol (1993) 1.18
Alterations of dopaminergic and noradrenergic innervations in motor cortex in Parkinson's disease. Ann Neurol (1991) 1.17
Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology (2000) 1.16
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis. J Neurochem (1991) 1.15
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet (1995) 1.15
Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J Neurosci (1992) 1.15
Cortical atrophy in senile dementia of the Alzheimer type is mainly due to a decrease in cortical length. Acta Neuropathol (1985) 1.15
Sensory maps in the claustrum of the cat. Nature (1980) 1.13
Fiber connections of the basal ganglia. Prog Brain Res (1979) 1.12
A subcortico-cortical cholinergic system is affected in Parkinson's disease. Brain Res (1983) 1.12
Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience (1999) 1.11
Apoptosis in dopaminergic neurons of the human substantia nigra during normal aging. Histol Histopathol (1997) 1.11
Input-output organization of the sensorimotor striatum in the squirrel monkey. J Neurosci (1994) 1.10
A microelectrophoretic delivery technique for use with horseradish peroxidase. Brain Res (1974) 1.10